HSP90AA1 and diffuse large B-cell lymphoma: As observed with doxycycline treatment, CSN5 knockdown resulted in reduction in the levels of several HSP90 client proteins as well as HSP70 and HSP90 proteins in both DLBCL cells (Figure 7B) and non-lymphoma cells (Supplementary Figure 7).